Chemistry:O-2172

From HandWiki

O-2172 is a drug developed by Organix Inc, which acts as a stimulant and potent dopamine reuptake inhibitor. It is an analogue of methylphenidate where the phenyl ring has had a 3,4-dichloro substitution added, and the piperidine ring has been replaced by cyclopentane. It is around 1/3 the potency of methylphenidate, demonstrating that even with the important binding group of the nitrogen lone pair removed entirely, selective DAT binding and reuptake inhibition is still possible.[1][2]

It has been sold as a designer drug under the name DCCPM.[3]

See also

References

  1. "Synthesis and evaluation of dopamine and serotonin transporter inhibition by oxacyclic and carbacyclic analogues of methylphenidate". Journal of Medicinal Chemistry 46 (8): 1538–1545. April 2003. doi:10.1021/jm0205292. PMID 12672255. 
  2. "Dopamine transporter ligands: recent developments and therapeutic potential". Current Topics in Medicinal Chemistry 6 (17): 1825–1843. 2006. doi:10.2174/156802606778249775. PMID 17017960. 
  3. "462 O-2172 (DCCPM)" (in English). Psychoactive products market observation Annual review. Trend analysis. (AIPSIN) (56). August 2024. doi:10.13140/RG.2.2.21830.28480. https://rgdoi.net/10.13140/RG.2.2.21830.28480. Retrieved September 8, 2025.